Analyzing ERBA Diagnostics (OTCMKTS:ERBA) & Sintx Technologies (NASDAQ:SINT)

ERBA Diagnostics (OTCMKTS:ERBA) and Sintx Technologies (NASDAQ:SINT) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.

Earnings and Valuation

This table compares ERBA Diagnostics and Sintx Technologies”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ERBA Diagnostics	N/A	N/A	N/A	N/A	N/A
Sintx Technologies	$1.23 million	6.79	-$11.02 million	($50.56)	-0.07

ERBA Diagnostics has higher earnings, but lower revenue than Sintx Technologies.

Profitability

This table compares ERBA Diagnostics and Sintx Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ERBA Diagnostics	N/A	N/A	N/A
Sintx Technologies	-483.85%	-203.66%	-104.76%

Insider and Institutional Ownership

18.4% of Sintx Technologies shares are owned by institutional investors. 88.1% of ERBA Diagnostics shares are owned by company insiders. Comparatively, 0.0% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and recommmendations for ERBA Diagnostics and Sintx Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ERBA Diagnostics	0	0	0	0	0.00
Sintx Technologies	0	0	1	0	3.00

Sintx Technologies has a consensus target price of $28.00, suggesting a potential upside of 742.11%. Given Sintx Technologies’ stronger consensus rating and higher probable upside, analysts clearly believe Sintx Technologies is more favorable than ERBA Diagnostics.

Summary

Sintx Technologies beats ERBA Diagnostics on 5 of the 9 factors compared between the two stocks.

About ERBA Diagnostics

ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures, and markets diagnostic test kits or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. It manufactures scientific and laboratory instruments, such as Mago 4, Mago 4S, and Mago Plus systems, which perform tests in an automated mode; sells other diagnostic products manufactured by third parties in Italy; and develops, manufactures, and markets raw materials, such as antigens that are used in the production of diagnostic kits. The company also develops, manufactures, and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers. In addition, the company provides instruments for blood cell counting and blood analysis; supplies reagents and other consumable materials; sells diabetic testing products, including the DS5 instrument, dispenser, and associated reagent kits, which measure long-term glucose control in diabetic patients; and offers equipment for use in the field of human and veterinary hematology. Further, it manufactures and sells liquid stable, diagnostics chemistry reagents used for in vitro diagnostics testing. The company markets its products through its sales force to hospitals, reference laboratories, clinical laboratories, and research laboratories, as well as to other commercial companies that manufacture diagnostic products in the United States; and through sales representatives and independent agents in Italy, as well as through independent distributors internationally. The company was founded in 1980 and is headquartered in Miami Lakes, Florida. ERBA Diagnostics, Inc. is a subsidiary of ERBA Diagnostics Mannheim GmbH.

About Sintx Technologies

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.